Harbor Investment Advisory’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$258K Hold
1,646
0.02% 376
2026
Q1
$251K Hold
1,646
0.02% 365
2025
Q4
$227K Buy
1,646
+11
+0.7% +$1.44K 0.02% 384
2025
Q3
$210K Sell
1,635
-57
-3% -$6.96K 0.02% 388
2025
Q2
$205K Sell
1,692
-137
-7% -$15.4K 0.02% 369
2025
Q1
$204K Hold
1,829
0.02% 368
2024
Q4
$178K Hold
1,829
0.02% 369
2024
Q3
$210K Hold
1,829
0.02% 335
2024
Q2
$195K Sell
1,829
-11
-0.6% -$1.1K 0.02% 336
2024
Q1
$178K Buy
1,840
+11
+0.6% +$1.13K 0.02% 355
2023
Q4
$185K Sell
1,829
-36
-2% -$3.48K 0.02% 334
2023
Q3
$190K Buy
1,865
+93
+5% +$9.44K 0.02% 315
2023
Q2
$179K Sell
1,772
-123
-6% -$12.3K 0.02% 364
2023
Q1
$174K Hold
1,895
0.03% 372
2022
Q4
$172K Sell
1,895
-40
-2% -$3.37K 0.03% 369
2022
Q3
$147K Hold
1,935
0.02% 386
2022
Q2
$164K Hold
1,935
0.03% 371
2022
Q1
$170K Buy
1,935
+122
+7% +$10.6K 0.02% 404
2021
Q4
$159K Hold
1,813
0.02% 421
2021
Q3
$148K Hold
1,813
0.02% 433
2021
Q2
$165K Buy
1,813
+78
+4% +$6.95K 0.02% 397
2021
Q1
$148K Sell
1,735
-314
-15% -$28.2K 0.02% 397
2020
Q4
$193K Sell
2,049
-130
-6% -$11.4K 0.03% 317
2020
Q3
$189K Sell
2,179
-517
-19% -$44.8K 0.04% 286
2020
Q2
$235K Buy
2,696
+78
+3% +$6.73K 0.05% 244
2020
Q1
$216K Buy
2,618
+14
+0.5% +$1.25K 0.06% 224
2019
Q4
$247K Buy
+2,604
New +$234K 0.06% 227

Other funds holding NVS

Harbor Investment Advisory's NVS Position: Q2 2026 in Review

Harbor Investment Advisory held its Novartis (NVS) position steady in Q2 2026 at 1,646 shares worth $258K. The position accounts for 0.02% of the portfolio, ranked #376.

Harbor Investment Advisory first reported a position in NVS in Q4 2019 and has held it in 27 quarters since. 545 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Harbor Investment Advisory held 1,646 shares of Novartis worth $258K as of Q2 2026.
  • Harbor Investment Advisory left its Novartis share count unchanged in Q2 2026.
  • Novartis made up 0.02% of Harbor Investment Advisory's portfolio in Q2 2026, its #376 holding.
  • Harbor Investment Advisory first reported a position in Novartis in Q4 2019 and has held it in 27 quarters since.
  • 545 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Harbor Investment Advisory's 13F filing for Q2 2026, filed 7 Jul 2026.